Advertisement

Topics

Companies Related to "Durvalumab granted breakthrough designation locally advanced unresectable NSCLC" [Most Relevant Company Matches] RSS

13:45 EST 24th November 2017 | BioPortfolio

Here are the most relevant search results for "Durvalumab granted breakthrough designation locally advanced unresectable NSCLC" found in our extensive corporate database of over 50,000 company records.

Showing "Durvalumab granted breakthrough designation locally advanced unresectable NSCLC" Companies 1–25 of 2,600+

Relevant

Can-Fite BioPharma Ltd.

Can-Fite BioPharma Ltd. (NYSE MKT: CANF) (TASE: CFBI) is an advanced clinical stage drug development Company with a platform technology that is designed to address multi-billion dollar markets in the treatment of cancer, inflammatory disease and sexual dysfunction. The Company's lead drug candidate, Piclidenoson, is scheduled to enter Phase III trials in 2...


EntreMed, Inc.

EntreMed, Inc. is a clinical-stage pharmaceutical company focused on developing next generation multi-mechanism oncology and antiinflammatory drugs that target disease cells directly and the blood vessels that nourish them. EntreMed is focused on developing drugs that are safe and convenient, and provide the potential for improved patient outcomes. Panzem® (2-methoxyestradiol or 2ME2), one of t...

Advanced Placement LLC.

Advanced Placement was opened with the following goals in mind:1. Treat all people as people, not as numbers. Build relationships, not sales. Above all, remember that quality service is our first priority.2. Require that the Advanced staff remain current in today's employment issues, trends and laws. Encourage staff to achieve the CPC (Certified Personnel Consultant) designation.3. Get involved wi...


Gentium S.p.A.

Gentium S.p.A., located in Como, Italy, is a biopharmaceutical company focused on the development and manufacture of drugs to treat and prevent a variety of diseases and conditions, including vascular diseases related to cancer and cancer treatments. Defibrotide, the Company's lead product candidate, is an investigational drug that has been granted Orphan ...

MindFrame, Inc.

MindFrame Inc. is a pioneer in developing optimized technologies for patients experiencing ischemic stroke. The breakthrough MindFrame Therapy Solutions portfolio comprises some of the most advanced device design technology that delivers exceptional rapid flow restoration and clot extraction intended to help clinicians provide improved clinical outcomes fo...

Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...

Emmaus Life Sciences, Inc.

Emmaus Life Sciences is dedicated to the discovery, development and commercialization of innovative treatments and therapies for rare diseases. The Company’s research on sickle cell disease and sickle beta-0 thalassemia was initiated by Dr. Niihara at the Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center. The therapy has Orphan D...

vitateq biotechnology GmbH

Vitateq Biotechnology GmbH, founded in 2000, is a research-driven enterprise with ultimate expertise in proteomics and protein quantitation. We will provide novel medical breakthrough by developing innovative diagnostic and therapeutic products for treatments of infertility disorders and neurodegenerative ailments. The company creates value by focusing on current medical need and quality of life. ...

Estech Systems, Inc.

Estech Systems, Inc. (ESI) designs and manufactures high-performance phone systems and cloud services for businesses and organizations. ESI uses advanced technology to design IP and digital communications systems that integrate built-in capabilities, advanced features, and highly differentiated applications into flexible products that are easy-to-use and k...

Aeris Therapeutics, LLC

Aeris Therapeutics is a medical technology company developing and commercializing the AeriSeal System, a breakthrough non-surgical treatment for patients with advanced emphysema. www.aerist.com

IMBiotechnologies Ltd

IMBio is a privately held Canadian biotechnology company focused on developing medical device products for use in the area of embolotherapy. Lead product, OCL 500 microspheres for the treatment of unresectable/inoperable hypervascularized tumours has received marketing clearance from the FDA in the U.S. Other products in development include rapidly-dissolving, drug-eluting and/or radio-labelle...

GelTex Incorporated

We are dedicated to having a positive effect on the lives of people living with illness and disease. We have demonstrated this by bringing important new therapies from discovery to market. GelTex’s first product, Renagel® brand sevelamer hydrochloride, was granted marketing approval by the U.S. Food and Drug Administration (FDA) in October 1998 for the reduction of serum phosphorus in hemodialy...

Make-a-Wish Foundation of Greater Ohio, Kentucky and Indiana

The Make-A-Wish Foundation(R) of Greater Ohio, Kentucky & Indiana is celebrating 25 years of inspiring lives, one wish at a time. Since the first wish was granted in 1984, this chapter has granted more than 7,300 magical wishes. This milestone year, the Chapter will work to fulfill the wishes of a record-breaking 800 local children. There are so many ways that you can help create joyful moments ...

Tercica

Tercica, Inc., based in Brisbane, Calif., is a biopharmaceutical company committed to improving endocrine health. We are helping patients by partnering with the scientific and medical community to develop and commercialize therapeutics for growth and other endocrine disorders. In January 2006, less than four years after Tercica was founded, we commercially launched Increlex™ (mecasermin [rDNA ...

Probably Relevant

Imperium, Inc.

Imperium, Inc. is a privately-held Maryland "C" corporation that develops and manufactures advanced ultrasound imaging systems. Dr. Marvin E. Lasser, the former chief scientist of the US Army and director of research for Ford (Philco Division) founded the company in 1996. Imperium sells its products through direct and indirect sales channels, and through flagship OEM partners in different industri...

EntreMed Incorporated

EntreMed, Inc. is a clinical-stage pharmaceutical company focused on developing multi-mechanism oncology drugs that target disease cells directly and the blood vessels that nourish them. EntreMed is focused on developing drugs that are safe and convenient, and provide the potential for improved patient outcomes. EntreMed’s goal is to develop and commercialize therapeutics based on the Company...

Biotech Synergy

Biotech Synergy has secured in San Diego the necessary competences to bring this promising multi epitope cancer vaccine to latest stage development. Contrary to Dendreon individualized vaccine, EP-2101 is made of 10 peptides and is an off the shelf readily available vaccine for the HLA-A2 population, which represents 45% of the global NSCLC patients (100,0...

MagneMotion

MagneMotion provides Linear Synchronous Motors (LSMs) and advanced transport solutions for high performance assembly, process, test and manufacturing automation to industries including, Medical Device Assembly, Automotive, Pharmaceutical, Packaging, Optical and others. MagneMotion's LSM products are used to create faster, more efficient, and more reliable ...

For RF Surgical RF Surgical

RF Surgical Systems, Inc. is the market leader in the prevention and detection of retained surgical sponges. The RF Surgical Detection System is the preferred solution in more than 1,000 operating rooms, trauma and labor & delivery suites nationwide. RF Surgical Systems is based in Bellevue, Washington with R & D facilities in San Diego, California. The ad...

LogRhythm

LogRhythm, the leader in log management and SIEM 2.0, delivers log and security event management, file integrity monitoring, and network and user monitoring in a single integrated solution. LogRhythm empowers organizations to comply with regulations, secure their networks, and optimize IT operations. The company received this year’s coveted “Reco...

OncoGenex Technologies Inc.

OncoGenex Technologies Inc. (OncoGenex) is a clinical-stage biotechnology company dedicated to improving survival and quality of life of cancer patients by developing targeted therapeutics for treatment-resistant and metastatic cancer. The company's lead drug candidate, OGX-011, has commenced Phase 2 studies in prostate cancer (2), NSCLC and breast cancer. OGX-427 is in preclinical development and...

CytRx

CytRx Corporation (NASDAQ: CYTR), located in Los Angeles, California, is a biopharmaceutical company engaged in the development of high-value therapeutics utilizing its core technologies in small molecule drugs, RNAi drug discovery and DNA vaccines. CytRx's small molecule drug candidates provide cellular protection by activating "molecular chaperone" proteins that can repair or degrade proteins ...

Living Proof, Inc.

Living Proof is a private beauty company based in Cambridge, MA. The company was co-founded in 2005 by Dr. Robert Langer, the David H. Koch Institute Professor at MIT, and Jon Flint, the co-founder of Polaris Partners. Living Proof invents and markets, worldwide, proprietary beauty products that are developed using advanced biotechnology and materials scie...

Dendritic NanoTechnologies Inc

Dendritic NanoTechnologies Inc. (DNT) is the world’s leading developer and provider of advanced dendritic polymers. DNT has breakthrough technology that provides the vehicle — the targeting and delivery mechanisms — for a vast array of diagnostics and therapeutics currently in development in the biotechnology and pharmaceutical industries.DNT is a U.S. company incorporated in 2003 and locate...

Arjuna Natural Extracts Ltd

For more than 27 years, Arjuna Natural Extracts Ltd has been India’s leading manufacturer and exporter of standardized botanical extracts for pharmaceutical and nutraceutical industries. Established in 1989, the company has grown in epic proportion with customers in 40 countries. The company has 33 granted international patents to its credit, with the ...


More From BioPortfolio on "Durvalumab granted breakthrough designation locally advanced unresectable NSCLC"

Quick Search
Advertisement
 

Corporate Database Quicklinks